Clinical Trials Logo
  1. Home
  2. Placebo
  3. NCT00241995
  4. Details
NCT00241995 Clinical Trial

Antiglutamate Anticonvulsants in the Treatment of Alcohol Withdrawal Syndrome

Placebo Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT00241995
Other study ID # RCT-RCT_LOND_GAT_AWS_2003
Secondary ID
Status Completed
Phase N/A
First received October 17, 2005
Last updated October 17, 2006

Study information
Verified date October 2005
Source St. Petersburg State Pavlov Medical University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The study is aimed to evaluate the efficacy of antiglutamate anticonvulsants (topiramate, lamotrigine, and memantine) in the treatment of alcohol withdrawal syndrome

Recruitment information / eligibility
Status Completed
Enrollment 0
Est. completion date
Est. primary completion date
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 20 Years to 60 Years
Eligibility Inclusion Criteria:

Alcohol dependence Alcohol withdrawal syndrome

Exclusion Criteria:

Drug dependence Major psychiatric diagnoses Severe somatic illness

Study Design

Related Conditions & MeSH terms

Intervention

Drug:
• Anticonvulsants

Locations
Country Name City State
n/a

Sponsors (1)
Lead Sponsor Collaborator
St. Petersburg State Pavlov Medical University
See also
  Status Clinical Trial Phase
Completed NCT04852315 - Acute Caffeine Ingestion on Futsal Performance N/A
Completed NCT05427409 - Ingestion of Beta-alanine Effects in Well-trained Tennis Players N/A
Completed NCT05425563 - Effects of Expectations on Negative Affect, Perceived Cognitive Effort, and Pain N/A
Recruiting NCT05007561 - Understanding How Opioids Affect the Experiential and Neural Signatures of Social Experiences Early Phase 1
Recruiting NCT03897998 - Neural Correlates of Hypoalgesia Driven by Observation Phase 2
Recruiting NCT04851301 - Neural Mechanisms of Immersive Virtual Reality in Chronic Pain Phase 1/Phase 2
Completed NCT04359147 - The Role of Stress Neuromodulators in Decision Making Under Risk and Selective Attention to Threat N/A
Recruiting NCT05145764 - Suvorexant as an Adjunct to Buprenorphine in Persons Who Use Fentanyl Phase 2
Completed NCT01167478 - Neurophysiological Reserve With Caffeine Manipulation N/A
Completed NCT05337527 - Neuromuscular Responses to Acute Beetroot Ingestion in Women Older Adults N/A
Terminated NCT01656577 - Pexacerfont for Stress-induced Food Craving Phase 0
Completed NCT04361968 - Combining Animal-assisted Intervention and Placebo-induced Analgesia N/A
Completed NCT03754062 - Pharmacological Modulation of Belief Salience Phase 1
Not yet recruiting NCT04317157 - Placebo Effects Investigated by Different Experimental Designs N/A
Completed NCT01361633 - The Cognitive Enhancing Effects of D-Cycloserine Among Non-Demented Elderly Phase 2
Completed NCT05209126 - Impact of Beetroot Juice Ingestion on Female Rugby Performance N/A
Completed NCT05521347 - Caffeine Supplementation Improves the Cognitive Abilities and Shooting Performance of Trained E-sports Players N/A
Completed NCT04975360 - Delayed-release Bedtime Caffeine and Sleep Inertia Symptoms Immediately Upon Awakening N/A
Completed NCT04671043 - Caffeine Ingestion to Counter the Exercise-mediated Fall in Glycaemia in Type 1 Diabetes N/A
Completed NCT01011465 - The Biology of Resilience N/A